Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Association between human papillomavirus status and health-related quality of life in oropharyngeal and oral cavity cancer survivors

Kjeldsted, Eva ; Dalton, Susanne Oksbjerg ; Frederiksen, Kirsten ; Andersen, Elo ; Nielsen, Anni Linnet ; Stafström, Martin LU and Kjaer, Trille Kristina (2020) In Oral Oncology 109.
Abstract

Objectives: The human papillomavirus (HPV) is a risk factor for a subgroup of head and neck cancers (HNC). HPV-positive and HPV-negative HNC patients encompass heterogeneous groups regarding risk factors, sociodemographic and clinical characteristics, which may influence health-related quality of life (HRQL) differently. Since this has been sparsely studied, our study investigated the association between HPV status and HRQL in HNC survivors in Denmark. Materials and methods: This cross-sectional study included 179 recurrence-free oropharyngeal and oral cavity squamous cell carcinoma (OSCC) survivors. HRQL was assessed on the EORTC QLQ-C30 and QLQ-H&N35 questionnaires. Linear and logistic regression models were adjusted for... (More)

Objectives: The human papillomavirus (HPV) is a risk factor for a subgroup of head and neck cancers (HNC). HPV-positive and HPV-negative HNC patients encompass heterogeneous groups regarding risk factors, sociodemographic and clinical characteristics, which may influence health-related quality of life (HRQL) differently. Since this has been sparsely studied, our study investigated the association between HPV status and HRQL in HNC survivors in Denmark. Materials and methods: This cross-sectional study included 179 recurrence-free oropharyngeal and oral cavity squamous cell carcinoma (OSCC) survivors. HRQL was assessed on the EORTC QLQ-C30 and QLQ-H&N35 questionnaires. Linear and logistic regression models were adjusted for sociodemographic, clinical and lifestyle factors. Results: Most unadjusted results showed better HRQL among HPV-positive (n = 119) compared to HPV-negative (n = 60) OSCC survivors (average 18 months since diagnosis). After adjustments, the HPV-positive survivors reported higher role functioning (mean difference [MD] 9.2, 95% confidence interval [CI] 0.1 to –18.4), and fewer problems with speech (MD −9.0, 95% CI −18.0 to −0.1), sexuality (MD −21.9, 95% CI −38.0 to −5.9) and opening mouth (MD −13.7, 95% CI −26.6 to −0.8) compared to HPV-negative survivors. Conclusion: Our findings support that HPV-positive OSCC survivors experience better HRQL than HPV-negative survivors. However, results indicate that sociodemographic, clinical and lifestyle factors explain most of the association between HPV status and HRQL. Findings suggest increased focus on the HPV-negative OSCC survivors with deteriorated HRQL in rehabilitation programs and future research to investigate the long-term effects of treatment among HPV-positive OSCC survivors who may develop symptoms later in survivorship.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Head and neck cancer, HPV, Human papillomavirus, Late effects, Quality of life
in
Oral Oncology
volume
109
article number
104918
publisher
Elsevier
external identifiers
  • pmid:32795908
  • scopus:85089219310
ISSN
1368-8375
DOI
10.1016/j.oraloncology.2020.104918
language
English
LU publication?
yes
id
c1868e67-596e-41e6-8907-cfa978d76921
date added to LUP
2020-08-17 12:14:02
date last changed
2024-03-05 03:18:23
@article{c1868e67-596e-41e6-8907-cfa978d76921,
  abstract     = {{<p>Objectives: The human papillomavirus (HPV) is a risk factor for a subgroup of head and neck cancers (HNC). HPV-positive and HPV-negative HNC patients encompass heterogeneous groups regarding risk factors, sociodemographic and clinical characteristics, which may influence health-related quality of life (HRQL) differently. Since this has been sparsely studied, our study investigated the association between HPV status and HRQL in HNC survivors in Denmark. Materials and methods: This cross-sectional study included 179 recurrence-free oropharyngeal and oral cavity squamous cell carcinoma (OSCC) survivors. HRQL was assessed on the EORTC QLQ-C30 and QLQ-H&amp;N35 questionnaires. Linear and logistic regression models were adjusted for sociodemographic, clinical and lifestyle factors. Results: Most unadjusted results showed better HRQL among HPV-positive (n = 119) compared to HPV-negative (n = 60) OSCC survivors (average 18 months since diagnosis). After adjustments, the HPV-positive survivors reported higher role functioning (mean difference [MD] 9.2, 95% confidence interval [CI] 0.1 to –18.4), and fewer problems with speech (MD −9.0, 95% CI −18.0 to −0.1), sexuality (MD −21.9, 95% CI −38.0 to −5.9) and opening mouth (MD −13.7, 95% CI −26.6 to −0.8) compared to HPV-negative survivors. Conclusion: Our findings support that HPV-positive OSCC survivors experience better HRQL than HPV-negative survivors. However, results indicate that sociodemographic, clinical and lifestyle factors explain most of the association between HPV status and HRQL. Findings suggest increased focus on the HPV-negative OSCC survivors with deteriorated HRQL in rehabilitation programs and future research to investigate the long-term effects of treatment among HPV-positive OSCC survivors who may develop symptoms later in survivorship.</p>}},
  author       = {{Kjeldsted, Eva and Dalton, Susanne Oksbjerg and Frederiksen, Kirsten and Andersen, Elo and Nielsen, Anni Linnet and Stafström, Martin and Kjaer, Trille Kristina}},
  issn         = {{1368-8375}},
  keywords     = {{Head and neck cancer; HPV; Human papillomavirus; Late effects; Quality of life}},
  language     = {{eng}},
  publisher    = {{Elsevier}},
  series       = {{Oral Oncology}},
  title        = {{Association between human papillomavirus status and health-related quality of life in oropharyngeal and oral cavity cancer survivors}},
  url          = {{http://dx.doi.org/10.1016/j.oraloncology.2020.104918}},
  doi          = {{10.1016/j.oraloncology.2020.104918}},
  volume       = {{109}},
  year         = {{2020}},
}